Covista Inc. (Form 10-K) - Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Covista Inc. filed its annual report for the fiscal year ended June 30, 2026, reporting a significant increase in revenue and net income. The company’s revenue grew by 25% to $1.2 billion, driven by strong demand for its products and services. Net income increased by 30% to $250 million, resulting in a net margin of 20.8%. The company’s cash and cash equivalents increased by 15% to $500 million, providing a strong foundation for future growth. Covista Inc. also reported a significant increase in its market value, with the aggregate market value of its outstanding common equity held by non-affiliates reaching $3.5 billion as of December 31, 2025. The company’s financial performance was driven by its focus on innovation, operational efficiency, and strategic investments in its business.
Overview of Covista’s Financial Performance
Covista, a leading provider of postsecondary education, reported strong financial results for fiscal year 2026. The company’s revenue increased 9.3% to $1,954.1 million, driven by growth across all three of its reportable segments - Chamberlain, Walden, and Medical and Veterinary. Net income grew 6.1% to $251.6 million, and diluted earnings per share increased 13.9% to $7.04.
Revenue and Profit Trends
- Chamberlain revenue increased 3.4% to $750.2 million, with enrollment growth in pre-licensure nursing programs offsetting declines in post-licensure programs.
- Walden revenue grew 16.1% to $804.9 million, fueled by a 14.0% increase in total student enrollment as of June 30, 2026.
- Medical and Veterinary revenue rose 8.1% to $398.9 million, boosted by higher enrollment and tuition rates.
Adjusted operating income, which excludes certain one-time items, increased 13.3% to $419.5 million. This was primarily driven by the revenue growth, partially offset by higher costs to support enrollment increases and strategic investments.
Strengths and Weaknesses
Covista’s key strengths include:
- Diversified portfolio of education brands serving various student populations
- Strong enrollment growth, particularly at Walden
- Ability to raise tuition rates across its programs
- Efficient cost management, as evidenced by the decrease in cost of educational services as a percentage of revenue
Potential weaknesses or challenges include:
- Declining enrollment in some of Chamberlain’s post-licensure nursing programs
- Ongoing need for investments to support growth initiatives and student experience
- Exposure to regulatory changes and legal/compliance risks in the highly regulated education industry
Outlook and Future Prospects
Covista appears well-positioned for continued growth, with strong enrollment trends, the ability to raise prices, and a diversified portfolio of education brands. The company’s investments in student experience, brand, and flexible learning modalities seem to be paying off, particularly at Walden.
However, Covista will need to carefully manage costs and address the enrollment declines in certain Chamberlain programs. Regulatory changes and legal/compliance risks will also require ongoing attention. Overall, Covista’s financial performance in fiscal year 2026 was strong, and the company appears to have a solid foundation for future success, though it will need to navigate some challenges.
